Continuous positive airway pressure (CPAP) in nonapneic asthma: A clinical review of current evidence
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
AVES
Abstract
The use of continuous positive airway pressure (CPAP) in asthma has been a point of debate over the past several years. Various studies, including those on animals and humans have attempted to understand the role and pathophysiology of CPAP in patients with either well controlled or poorly controlled asthma. The aim of this manuscript is to review the currently available literature on the physiologic and clinical effects of CPAP in animal models of asthma and on humans with stable asthma. © 2020 by Turkish Thoracic Society-.
Description
Keywords
Asthma, Bronchoconstriction, Continuous positive airway pressure, 1 alkyl 2 acetylglycerophosphocholine esterase, Acetylcholine, Bronchodilating agent, Budesonide, Carbachol, Corticosteroid, Heliox, Histamine, Immunoglobulin e, Interleukin 10, Interleukin 13, Interleukin 4, Interleukin 5, Interleukin 6, Ipratropium bromide, Methacholine, Ovalbumin, Prednisolone, Rna directed rna polymerase, Salbutamol, Thrombocyte activating factor, Tumor necrosis factor, Aerosol, Airway pressure, Airway resistance, Airway smooth muscle cell, Apnea hypopnea index, Artificial ventilation, Asthma control test, Chronic obstructive lung disease, Dendritic cell, Environmental factor, Eosinophil, Forced expiratory volume, Functional residual capacity, Human, Hyperactivity, Hyperpnea, Hypoventilation, Immune response, Lung injury, Lung lavage, Nonhuman, Noninvasive ventilation, Obesity, Oxygen therapy, Pathophysiology, Peak expiratory flow, Phenotype, Quality of life, Respiratory tract allergy, Review, Signal transduction, Smooth muscle contraction, Sputum analysis, Systematic review, Th2 cell